📰 Iagnostics News
Page 101 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
March 10, 2022
SINGAPORE, March 10, 2022 /PRNewswire/ -- Everlife Holdings Pte Ltd ("Everlife"), a leading market access and distribution company in India and South East Asia, has announced the completion
March 10, 2022
BioEcho Life Sciences receives two important hallmarks for its quality management – DIN EN ISO 9001:2015 and DIN EN ISO 13485:2016.
March 9, 2022
The Singapore lab will deliver clinical diagnostics services for infectious diseases
March 9, 2022
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with...
March 8, 2022
- Pharmaceutical and biotechnology companies are expected to witness rapid growth due to their increasing research spending, which leads to high usage of molecular diagnostic devices -
March 8, 2022
The world's largest study of the genetics of critical Covid-19, involving more than 57,000 people, has revealed fresh details about some of the biological mechanisms behind the severe form of the disease.
March 8, 2022
EKF Diagnostics has signed a partnership agreement with ABEC, a global provider of engineered solutions and services for biotech manufacturing.
March 8, 2022
CHICAGO, March 8, 2022 /PRNewswire/ -- According to the new market research report "Point of Care and Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy
March 8, 2022
Diagnostics developer Sherlock Biosciences has advanced its molecular diagnostic capabilities, which can now produce faster results on low-cost devices. The startup will use its Series B round of funding to expand the reach of its technology, potentially placing it directly in the hands of consumers around the world.
March 8, 2022
Manufacturers that conduct workplace drug and alcohol testing must be careful when addressing drug test results and employee disclosures of prescription medication use, especially as drug use has surged across the country during the COVID-19 pandemic.